The Modern Heart-Failure Regimen: Four Pillars and the New Drugs

From relieving symptoms to changing the future

For a long time, treating heart failure meant mostly relieving congestion with a diuretic — helping people breathe, but not changing how the illness unfolds. The modern era is different. We now have several drugs that, in the common form with a weak pump (HFrEF, a low ejection fraction), each independently help people live longer and stay out of hospital. Crucially, they do this by interrupting the harmful remodelling in which a stressed heart keeps enlarging and weakening.

The four pillars

Modern guidelines describe four pillars for a weak-pump heart, started together and built up over weeks. Each comes from a family you already met in this track, plus two newer arrivals. The goal is to get a person onto all four, at tolerated doses, because their benefits add up.

1. A renin–angiotensin blocker — historically an ACE inhibitor or ARB, now often upgraded to sacubitril-valsartan, which adds a second mechanism that preserves the body's own beneficial natriuretic peptides.
2. A [[card-beta-blocker|beta-blocker]] — calming the over-driven heart so it can recover; in heart failure, gentleness over time helps the pump grow stronger.
3. A mineralocorticoid-receptor antagonist — a potassium-sparing diuretic-like drug (such as spironolactone) that further blocks a harmful hormone signal.
4. An [[sglt2-inhibitor|SGLT2 inhibitor]] — first developed for diabetes, now a heart-failure pillar in its own right, helping the heart even in people without diabetes.

Sitting alongside the pillars is the loop diuretic, not as a pillar but as the comfort drug: its dose is adjusted up and down to keep the body's fluid just right, while the four pillars do the long-term work of protecting the heart.

Why layered, and how it comes together

Why four drugs instead of one strong one? Because each pillar interrupts the failing heart's downward spiral at a different point, their benefits stack rather than overlap. Trials show that each, added on top of the others, lowers the risk of dying or being hospitalised. The art lies in starting low, building up gradually, and watching the blood pressure, potassium and kidney function as the regimen grows.

A typical HFrEF regimen, layer by layer

  Comfort  Loop diuretic ...... dose flexed to keep
                              fluid balance right

  PILLARS (each lowers death / hospitalisation):
   1  Sacubitril-valsartan ... blocks angiotensin +
                              boosts natriuretic peptides
   2  Beta-blocker ........... calms the over-driven heart
   3  MRA (spironolactone) ... blocks aldosterone signal
   4  SGLT2 inhibitor ........ helps heart & kidney,
                              even without diabetes

  Principle: start all four early at low doses,
  uptitrate over weeks, monitor BP, potassium,
  and kidney function as you go.

  Devices may be added on top (e.g. an ICD for
  sudden-death protection, or resynchronisation)
  but the four pillars are the drug foundation.

This is the fitting end to the track. Look back and you will see every theme return: blood-flow drugs, load-lighteners, fluid control, rhythm care and the long-game vessel drugs all reappear here, woven into one strategy for one of cardiology's hardest problems. Understanding the jobs from guide one is what lets this modern regimen make sense rather than feel like a random handful of pills.